Published in Proc Natl Acad Sci U S A on June 01, 1991
Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol (1993) 3.32
Proteins connecting the nuclear pore complex with the nuclear interior. J Cell Biol (1999) 2.60
Identification of protein p270/Tpr as a constitutive component of the nuclear pore complex-attached intranuclear filaments. J Cell Biol (1997) 2.32
An overview of the c-MET signaling pathway. Ther Adv Med Oncol (2011) 1.95
c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol (2011) 1.81
Targeting the hepatocyte growth factor-cMET axis in cancer therapy. J Clin Oncol (2012) 1.77
Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol Cell Biol (2006) 1.76
Tpr, a large coiled coil protein whose amino terminus is involved in activation of oncogenic kinases, is localized to the cytoplasmic surface of the nuclear pore complex. J Cell Biol (1994) 1.52
Nuclear pore proteins and cancer. Semin Cell Dev Biol (2009) 1.44
Functional analysis of Tpr: identification of nuclear pore complex association and nuclear localization domains and a role in mRNA export. J Cell Biol (1998) 1.43
Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci U S A (2010) 1.37
Amino acid substitutions of coiled-coil protein Tpr abrogate anchorage to the nuclear pore complex but not parallel, in-register homodimerization. Mol Biol Cell (2001) 1.17
Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci U S A (1995) 1.13
Role of the nuclear envelope in genome organization and gene expression. Wiley Interdiscip Rev Syst Biol Med (2011) 1.04
Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy. World J Gastroenterol (2006) 0.96
Activating MET kinase rearrangements in melanoma and Spitz tumours. Nat Commun (2015) 0.92
The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment. Onco Targets Ther (2014) 0.91
Localization of nucleoporin Tpr to the nuclear pore complex is essential for Tpr mediated regulation of the export of unspliced RNA. PLoS One (2012) 0.90
Aiding and abetting cancer: mRNA export and the nuclear pore. Trends Cell Biol (2013) 0.88
Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer (1995) 0.88
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome. Nat Commun (2015) 0.88
Advanced gastric cancer: Current treatment landscape and future perspectives. World J Gastroenterol (2016) 0.88
Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization. Br J Cancer (1999) 0.88
Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells. PLoS One (2013) 0.84
A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers. Cancer Biol Ther (2014) 0.83
Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins. J Virol (1996) 0.81
Promise and challenges on the horizon of MET-targeted cancer therapeutics. World J Biol Chem (2015) 0.80
C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells. Clin Exp Metastasis (1998) 0.80
Value of c-Met for Predicting Progression of Precancerous Gastric Lesions in Rural Chinese Population. Chin J Cancer Res (2012) 0.80
Nucleoporin Nup98 mediates galectin-3 nuclear-cytoplasmic trafficking. Biochem Biophys Res Commun (2013) 0.79
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth. Front Pharmacol (2012) 0.79
Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer. Oncotarget (2016) 0.79
Esophageal cancer alters the expression of nuclear pore complex binding protein Hsc70 and eIF5A-1. Funct Integr Genomics (2013) 0.76
Orchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host Factors. Viruses (2016) 0.76
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma. J Hepatocell Carcinoma (2015) 0.75
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma. Oncogene (2016) 0.75
MET: roles in epithelial-mesenchymal transition and cancer stemness. Ann Transl Med (2017) 0.75
MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy. Ann Transl Med (2017) 0.75
The Nuclear Matrix Protein Megator Regulates Stem Cell Asymmetric Division through the Mitotic Checkpoint Complex in Drosophila Testes. PLoS Genet (2015) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
A human model of gastric carcinogenesis. Cancer Res (1988) 6.52
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature (1986) 5.88
Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85
An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell (1984) 4.78
Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature (1984) 4.30
Mechanism of met oncogene activation. Cell (1986) 4.20
PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell (1990) 3.98
The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science (1986) 3.53
Tyrosine kinase receptor indistinguishable from the c-met protein. Nature (1989) 3.00
Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol (1989) 2.81
Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. Oncogene (1989) 2.67
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature (1987) 2.60
Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci U S A (1983) 2.08
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene (1989) 1.94
Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer. Proc Natl Acad Sci U S A (1985) 1.83
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A (1986) 1.71
Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res (1987) 1.35
A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene. Nucleic Acids Res (1986) 1.33
Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines. Cancer Res (1984) 1.17
Activation of the met oncogene in the human MNNG-HOS cell line involves a chromosomal rearrangement. Carcinogenesis (1986) 1.04
A sensitive non-radioactive PCR-RFLP analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in DNAs of gastric cancer. Nucleic Acids Res (1988) 0.99
TPR-MET oncogenic rearrangement: detection by polymerase chain reaction amplification of the transcript and expression in human tumor cell lines. Proc Natl Acad Sci U S A (1990) 0.94
Mouse vimentin: structural relationship to fos, jun, CREB and tpr. Oncogene (1990) 0.93
Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice. Gan (1983) 0.91
Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer (1989) 0.89
Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization. Cancer Res (1987) 0.87
Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers. Gastroenterology (1987) 0.86
Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis. Jpn J Cancer Res (1986) 0.86
Analysis by pulsed field gel electrophoresis reveals complex rearrangements in two MET alleles in a chemically-treated human cell line, MNNG-HOS. Oncogene (1990) 0.84
Intestinal metaplasia and adenocarcinoma induced in the stomach of rats by N-propyl-N'-nitro-N-nitrosoguanidine. J Cancer Res Clin Oncol (1979) 0.84
Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells. Jpn J Cancer Res (1987) 0.81
A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer. Biochem Biophys Res Commun (1987) 0.79
Mechanism of activation of human ras genes cloned from a gastric adenocarcinoma and a pancreatic carcinoma cell line. Cancer Res (1986) 0.79
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A (2001) 4.80
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA (1994) 4.35
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Transmission of Helicobacter pylori among siblings. Lancet (2000) 3.78
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Chemical nature and biological effects of the aflatoxins. Bacteriol Rev (1966) 3.44
Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37
Long term follow up of patients treated for Helicobacter pylori infection. Gut (2005) 3.09
Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol (1989) 2.81
Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans. Gastroenterology (1990) 2.64
Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res (1996) 2.56
Lung cancer in nonsmoking women: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev (1993) 2.53
Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Proc Natl Acad Sci U S A (1977) 2.53
Ultrastructure of the gastric mucosa harboring Campylobacter-like organisms. Am J Clin Pathol (1986) 2.52
Aflatoxin B1: binding to DNA in vitro and alteration of RNA metabolism in vivo. Science (1966) 2.46
Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst (1970) 2.35
Passive smoking and lung cancer. Lancet (1983) 2.27
Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst (1976) 2.14
The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol (1995) 2.10
Gastric cancer in Colombia. I. Cancer risk and suspect environmental agents. J Natl Cancer Inst (1976) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Environmental tobacco smoke and lung cancer in nonsmoking women. A multicenter study. JAMA (1994) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci U S A (1987) 1.98
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res (1967) 1.82
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol (1993) 1.77
Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1996) 1.75
Histologic types of gastric carcinoma in high- and low-risk areas. Int J Cancer (1968) 1.73
In vitro reactions of aflatoxin B1-adducted DNA. Proc Natl Acad Sci U S A (1981) 1.73
Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst (1993) 1.72
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol (1996) 1.69
Precursors of gastric and esophageal cancer. Cancer (1982) 1.65
Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A (1978) 1.64
OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64
CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.62
Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int J Cancer (1999) 1.60
Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol (1985) 1.59
Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res (1981) 1.59
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst (2000) 1.55
High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol (1992) 1.54
Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol (1988) 1.54
Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol (2001) 1.51
Is gastric carcinoma an infectious disease? N Engl J Med (1991) 1.50
Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.48
Gastric carcinoma in the young. Cancer (1987) 1.47
Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environ Mol Mutagen (2000) 1.46
p53 alteration in gastric precancerous lesions. Am J Pathol (1994) 1.45
Prolonged achlorhydria and gastric neoplasia: is there a causal relationship? Gastroenterology (1993) 1.45
Geographic pathology of latent prostatic carcinoma. Int J Cancer (1982) 1.44
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc Natl Acad Sci U S A (2000) 1.44
Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. J Natl Cancer Inst (1992) 1.43
Improved procedure for production of cytochalasin E and tremorgenic mycotoxins by Aspergillus clavatus. Appl Environ Microbiol (1976) 1.42
The impact of vaginal cytology on cervical cancer risks in Cali, Colombia. Int J Cancer (1984) 1.41
Histopathology of gastric dysplasias: correlations with gastric juice chemistry. Am J Surg Pathol (1979) 1.40
Precursor lesions of oesophageal cancer in young people in a high-risk population in China. Lancet (1989) 1.38
Sequential morphologic changes in aflatoxin B carcinogenesis in the rat. Cancer Res (1968) 1.33
Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int J Cancer (1997) 1.32
Mycotoxins. Annu Rev Pharmacol (1975) 1.29
Developments in the epidemiology of stomach cancer over the past decade. Cancer Res (1975) 1.26
Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol (2001) 1.26
CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect (2009) 1.25
Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. Cancer Res (1992) 1.23
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis (1988) 1.23
Gastric dysplasia. Significance and pathologic criteria. Cancer (1984) 1.23
Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer (1971) 1.23
Prevalence of latent prostate carcinoma in two U.S. populations. J Natl Cancer Inst (1980) 1.23
The epidemiology of colorectal polyps: prevalence in New Orleans and international comparisons. Cancer (1977) 1.23
Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev (1994) 1.22
Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.21
Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat Res (1996) 1.21
Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol (1995) 1.19
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Am J Gastroenterol (2001) 1.18
Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect (1985) 1.18
Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. Cancer Res (1980) 1.18
A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer (1992) 1.17
Excretion of an aflatoxin-guanine adduct in the urine of aflatoxin B1-treated rats. Cancer Res (1981) 1.17
Aflatoxin metabolism in humans: detection of metabolites and nucleic acid adducts in urine by affinity chromatography. Proc Natl Acad Sci U S A (1985) 1.17
The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res (1980) 1.16
Epidemiologic patterns of Hodgkin's disease. Int J Cancer (1971) 1.15
Time course of alterations of rat liver polysome profiles induced by aflatoxin B 1 . Biochem Pharmacol (1969) 1.14
Cancer of the colon and rectum and adenomatous polyps. A review of epidemiologic findings. Cancer (1971) 1.14
Monoclonal antibody to aflatoxin B1-modified DNA detected by enzyme immunoassay. Proc Natl Acad Sci U S A (1981) 1.14
Occupational exposure to environmental tobacco smoke. JAMA (1996) 1.13
Risk factors for maternal mortality: a case-control study in Dakar hospitals (Senegal). Afr J Reprod Health (1997) 1.13
Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc Natl Acad Sci U S A (1986) 1.13
Dietary determinants of gastric cancer in south Louisiana inhabitants. J Natl Cancer Inst (1985) 1.12
Gastric cancer in Colombia. IV. Nitrite and other ions in gastric contents of residents from a high-risk region. J Natl Cancer Inst (1979) 1.12
Epidemiological correlations between diet and cancer frequency. Cancer Res (1981) 1.12
Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci (1993) 1.10
The epidemiology of large-bowel cancer. Adv Cancer Res (1978) 1.10
Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv (1989) 1.10
Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev (1996) 1.10
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev (1993) 1.09